These findings are complementary to recent work in tumor-associated myeloid cells and may help explain why SPD generates a protumorigenic environment (22), as it can increase immune suppression through enhancement of myeloid cells while concomitantly decreasing immune activation though the depletion and reduced cytokine production among CD8+ T cells. Here, CD8A is linked to Platelet storage pool disease.